Lars Kjøller‐Hansen

1.0k total citations
18 papers, 314 citations indexed

About

Lars Kjøller‐Hansen is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Lars Kjøller‐Hansen has authored 18 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Surgery. Recurrent topics in Lars Kjøller‐Hansen's work include Cardiac Imaging and Diagnostics (9 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers) and Cardiac Valve Diseases and Treatments (5 papers). Lars Kjøller‐Hansen is often cited by papers focused on Cardiac Imaging and Diagnostics (9 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers) and Cardiac Valve Diseases and Treatments (5 papers). Lars Kjøller‐Hansen collaborates with scholars based in Denmark, Sweden and Norway. Lars Kjøller‐Hansen's co-authors include Rolf Steffensen, Peer Grande, Thomas Engstrøm, Gunnar V.H. Jensen, Gregg W. Stone, Ziad A. Ali, David Erlinge, Mitsuaki Matsumura, Jonas Persson and Hans Erik Bøtker and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Lars Kjøller‐Hansen

16 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Kjøller‐Hansen Denmark 8 237 159 130 41 28 18 314
Koji Ono Japan 12 266 1.1× 125 0.8× 134 1.0× 42 1.0× 11 0.4× 22 328
Yun Ha Choi South Korea 11 199 0.8× 259 1.6× 195 1.5× 81 2.0× 18 0.6× 29 368
N. Moes Austria 9 170 0.7× 264 1.7× 168 1.3× 79 1.9× 42 1.5× 15 355
Masahiko Kanna Japan 10 256 1.1× 80 0.5× 144 1.1× 19 0.5× 21 0.8× 18 340
Jun Sugisawa Japan 7 260 1.1× 168 1.1× 238 1.8× 28 0.7× 13 0.5× 14 349
Alfredo M. Rodriguez–Granillo Argentina 11 304 1.3× 325 2.0× 149 1.1× 68 1.7× 18 0.6× 26 425
Patrick Moon United States 4 129 0.5× 100 0.6× 186 1.4× 34 0.8× 16 0.6× 5 266
Mikihiro Kijima Japan 11 208 0.9× 267 1.7× 144 1.1× 67 1.6× 9 0.3× 28 341
M. Pfisterer Switzerland 6 340 1.4× 223 1.4× 88 0.7× 26 0.6× 11 0.4× 9 453
Naoki Nozawa Japan 11 336 1.4× 119 0.7× 157 1.2× 25 0.6× 25 0.9× 15 420

Countries citing papers authored by Lars Kjøller‐Hansen

Since Specialization
Citations

This map shows the geographic impact of Lars Kjøller‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Kjøller‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Kjøller‐Hansen more than expected).

Fields of papers citing papers by Lars Kjøller‐Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Kjøller‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Kjøller‐Hansen. The network helps show where Lars Kjøller‐Hansen may publish in the future.

Co-authorship network of co-authors of Lars Kjøller‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Kjøller‐Hansen. A scholar is included among the top collaborators of Lars Kjøller‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Kjøller‐Hansen. Lars Kjøller‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Maehara, Akiko, Michael Mæng, Lars Kjøller‐Hansen, et al.. (2025). Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy. International Journal of Cardiology Cardiovascular Risk and Prevention. 26. 200440–200440. 2 indexed citations
2.
Kjøller‐Hansen, Lars, Akiko Maehara, Henning Kelbæk, et al.. (2024). Impact of Lipidic Plaque on In-Stent and Stent Edge–Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy. Circulation Cardiovascular Interventions. 17(10). e014215–e014215.
3.
Kjøller‐Hansen, Lars, Henning Kelbæk, Evald Høj Christiansen, et al.. (2021). Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size. Cardiology. 146(6). 705–712. 8 indexed citations
4.
Stone, Gregg W., Akiko Maehara, Ziad A. Ali, et al.. (2020). Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. Journal of the American College of Cardiology. 76(20). 2289–2301. 120 indexed citations
5.
Kjøller‐Hansen, Lars, Henning Kelbæk, Evald Høj Christiansen, et al.. (2018). Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments. EuroIntervention. 14(7). 764–771. 6 indexed citations
6.
Jensen, Gunnar V.H., et al.. (2017). Prognostic Usefulness of Cardiopulmonary Exercise Testing for Managing Patients With Severe Aortic Stenosis. The American Journal of Cardiology. 120(5). 844–849. 6 indexed citations
7.
Jensen, Gunnar V.H., et al.. (2016). Observed change in peak oxygen consumption after aortic valve replacement and its predictors. Open Heart. 3(1). e000309–e000309. 2 indexed citations
9.
Sorensen, Lars, et al.. (2010). Percutaneous coronary intervention without onsite cardiac surgery.. PubMed. 57(11). A4202–A4202. 2 indexed citations
10.
11.
Kjøller‐Hansen, Lars, Rolf Steffensen, & Peer Grande. (2004). Effect of ramipril on postrevascularization prevalence of angina and quality of life. International Journal of Cardiology. 95(2-3). 159–165. 1 indexed citations
12.
Kjøller‐Hansen, Lars, Rolf Steffensen, & Peer Grande. (2004). Extended follow-up of patients randomly assigned in the angiotensin-converting enzyme inhibition post-revascularization study (APRES). American Heart Journal. 148(3). 475–480. 7 indexed citations
13.
Kjøller‐Hansen, Lars, Jens J. Thiis, Rolf Steffensen, & Peer Grande. (2003). Add-On Benefit to Coronary Artery Bypass Grafting of Treatment with Ramipril for Major Cardiac Events and Left Ventricular Remodeling in Intermediate-Risk Patients. 3(2). 73–81. 1 indexed citations
14.
Carstensen, Steen, Henning Bundgaard, Lars Kjøller‐Hansen, et al.. (2002). Between observer variation is not eliminated by standardised analysis of dobutamine–atropine stress echocardiography. International journal of cardiac imaging. 18(3). 169–179. 2 indexed citations
16.
Kjøller‐Hansen, Lars, Rolf Steffensen, & Peer Grande. (2000). The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES). Journal of the American College of Cardiology. 35(4). 881–888. 73 indexed citations
18.
Kjøller‐Hansen, Lars, S. Boesgaard, Jørn Bech Laursen, Jan Aldershvile, & Henrik E. Poulsen. (1993). [Importance of thiols (SH group) in the cardiovascular system].. PubMed. 155(45). 3642–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026